pulmonary arterial hypertension News
Most Popular pulmonary arterial hypertension Story
Analysts give Actelion's key lung drug 63% odds of success
Swiss biotech Actelion ($ATLN) could use a win for its experimental lung drug. In need for a new product to follow its big hit Tracleer, the company's big moment for its lung disease treatment Read more...
Latest Headlines
- January 31, 2012
- November 17, 2008
- May 23, 2008
- November 1, 2007
- September 7, 2007
- July 18, 2007
- June 25, 2007
- November 19, 2006
- November 19, 2006
- October 16, 2006
- October 1, 2006
- August 10, 2006
- July 24, 2006
- June 15, 2006
- April 2, 2006
- March 26, 2006
- March 23, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
